An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-10-28
- Target Recruit Count
- 85
- Registration Number
- NCT00000721
- Locations
- ๐บ๐ธ
Stanford CRS, Palo Alto, California, United States
A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-10-28
- Target Recruit Count
- 64
- Registration Number
- NCT00000743
- Locations
- ๐บ๐ธ
Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU, New Orleans, Louisiana, United States
๐บ๐ธUCLA CARE Center CRS, Los Angeles, California, United States
๐บ๐ธJohns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States
A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-10-28
- Target Recruit Count
- 400
- Registration Number
- NCT00000750
- Locations
- ๐บ๐ธ
UCLA Med Ctr / Pediatric, Los Angeles, California, United States
๐บ๐ธHarbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles, California, United States
๐บ๐ธUniv of Illinois College of Medicine / Pediatrics, Chicago, Illinois, United States
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma
- Conditions
- HIV InfectionsSarcoma, Kaposi
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-03
- Target Recruit Count
- 24
- Registration Number
- NCT00000681
- Locations
- ๐บ๐ธ
UCLA CARE Center CRS, Los Angeles, California, United States
๐บ๐ธPitt CRS, Pittsburgh, Pennsylvania, United States
๐บ๐ธSUNY - Buffalo, Erie County Medical Ctr., Buffalo, New York, United States
A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-10-27
- Target Recruit Count
- 140
- Registration Number
- NCT00000653
- Locations
- ๐บ๐ธ
St. Christopher's Hosp. for Children, Philadelphia, Pennsylvania, United States
๐บ๐ธChicago Children's CRS, Chicago, Illinois, United States
๐บ๐ธJohns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases, Baltimore, Maryland, United States
Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication
- Conditions
- HIV Infections
- Locations
- ๐บ๐ธ
Univ of Colorado Health Sciences Ctr, Denver, Colorado, United States
๐บ๐ธUniv of Miami School of Medicine, Miami, Florida, United States
๐บ๐ธNorthwestern Univ Med School, Chicago, Illinois, United States
A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)
- Conditions
- HIV Infections
A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2008-09-29
- Target Recruit Count
- 40
- Registration Number
- NCT00001088
- Locations
- ๐บ๐ธ
Vanderbilt Univ Hosp, Nashville, Tennessee, United States
๐บ๐ธUniv of Alabama at Birmingham, Birmingham, Alabama, United States
๐บ๐ธUniv of Rochester Med Ctr, Rochester, New York, United States
A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 94
- Registration Number
- NCT00001085
- Locations
- ๐บ๐ธ
The Ponce de Leon Ctr. CRS, Atlanta, Georgia, United States
๐บ๐ธRush Univ. Med. Ctr. ACTG CRS, Chicago, Illinois, United States
๐บ๐ธCook County Hosp. CORE Ctr., Chicago, Illinois, United States
The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 500
- Registration Number
- NCT00000999
- Locations
- ๐บ๐ธ
Louisiana State Univ Med Ctr / Tulane Med School, New Orleans, Louisiana, United States
๐บ๐ธBeth Israel Med Ctr / Peter Krueger Clinic, New York, New York, United States
๐บ๐ธUniv of Rochester Medical Center, Rochester, New York, United States